NALTREXONE/BUPRIOPION prolonged-release tablets (Mysimba®▼) - Pan Mersey APC Skip to main content Help with accessibility Skip to main navigation

NALTREXONE/BUPRIOPION prolonged-release tablets (Mysimba®▼)

Last Updated: 31 January 2018

Body System: Nervous system

Black

The Pan Mersey Area Prescribing Committee does not recommend the prescribing of NALTREXONE-BUPROPION 8 mg/90 mg prolonged-release tablets (Mysimba®▼) for managing overweight and obesity in accordance with NICE TA494.